Subscribe
The latest psychology and neuroscience discoveries.
My Account
  • Mental Health
  • Social Psychology
  • Cognitive Science
  • Psychopharmacology
  • Neuroscience
  • About
No Result
View All Result
PsyPost
PsyPost
No Result
View All Result
Home Exclusive Psychopharmacology

Use of illicit drugs other than marijuana is 20 percent higher among ‘teen ravers’

by New York University
May 18, 2015
in Psychopharmacology
(Photo credit: Caesar Sebastian)

(Photo credit: Caesar Sebastian)

Share on TwitterShare on Facebook
Stay informed on the latest psychology and neuroscience research—follow PsyPost on LinkedIn for daily updates and insights.

In recent years, the popularity of “electronic dance music” (EDM) and dance festivals has increased substantially throughout the US and worldwide.

Even though data from national samples suggests drug use among adolescents in the general US population has been declining, targeted samples have shown nightclub attendees tend to report high rates of drug use, above that of the general population. In spite of increasing deaths among dance festival attendees in recent years, no nationally representative studies have examined potential associations between nightlife attendance and drug use.

In order to inform prevention and harm reduction (for those who reject abstinence), data has been needed from nationally representative samples to determine the extent to which nightlife (or “rave”) attendees may in fact more likely to use various drugs.

A new study, published in Drug and Alcohol Dependence by researchers affiliated with New York University’s Center for Drug Use and HIV Research (CDUHR), is the first to examine the sociodemographic correlates of rave attendance and relationships between rave attendance and recent (12-month) use of various drugs in a representative US sample of high school seniors.

The study, “Illicit Drug Use among Rave Attendees in a Nationally Representative Sample of US High School Seniors,” used data from Monitoring the Future (MTF), a nationwide ongoing annual study of the behaviors, attitudes, and values of American secondary school students. The MTF survey is administered in approximately 130 public and private schools throughout 48 states in the US. Roughly 15,000 high school seniors are assessed annually. This study utilized MTF responses from 2011 to 2013, examining data from a total of 7,373 students who, in addition to reporting their sociodemographic data, alcohol and drug use, were asked how often they attended “raves.”

Researchers compared rates of recent use of various drugs according to whether or not any rave attendance was reported. They also examined differences by more frequent use (defined as use six or more times a year), and they also examined differences in use by level of rave attendance.

“One out of five students reported ever attending a rave, and 7.7% reported attending at least monthly,” said Joseph J. Palamar, PhD, MPH, a CDUHR affiliated researcher and an assistant professor of Population Health at NYU Langone Medical Center (NYULMC). “Females and highly religious students were less likely to attend raves, while students residing in cities, students with higher income and those who go out for fun multiple times per week were more likely to attend.”

Most notably, the study found that use of illicit drugs other than marijuana was about 20% higher among rave attendees compared to non-attendees. Moreover, rave attendees were more likely to report more frequent use for each of the 18 drugs assessed.

“Use of each illicit drug other than marijuana was at least twice as prevalent among rave attendees, and the common “club drugs” ketamine and GHB were both almost six-times more prevalent among attendees,” said Palamar. “Higher frequency of rave attendance was consistently associated with higher odds for reporting recent use of each of the drugs assessed, especially use of the party drugs LSD, ketamine, GHB and methamphetamine.”

A major limitation of this national data Palamar and his team analyzed was that the students who were asked about rave attendance were not asked about use of ecstasy (MDMA, commonly referred to as “Molly”). In addition, he cautioned that the survey questions they examined did not define “rave” for the students so it is unknown whether all respondents considered dance festivals or nightclub parties “raves”.

“Our research findings shouldn’t be used to label or stigmatize the latest generation of nightlife and festival attendees. While rates of use are in fact higher in this population we need to keep in mind that two-thirds of rave attendees reported that they did not use drugs other than marijuana,” notes Palamar.

Accordingly, the study’s findings should inform prevention and much needed harm reduction efforts around rave attendees.

“The summer festival season is about to begin,” said Palamar. “I commend the recent efforts of festival promoters to ensure safety of attendees–for example, serving free water and having medical staff present to help patrons in need. However, I do worry that increased presence of law enforcement may lead to riskier drug taking practices among those who reject abstinence. We urge patrons to look out for one another to ensure everyone’s safety.”

Palamar and the other authors of this study advocate for the availability of drug testing services at or outside of raves and realistic education initiatives, such as social media campaigns, to prevent use and adverse outcomes, which would likely reduce poisonings in the new cohort of partiers.

TweetSendScanShareSendPinShareShareShareShareShare

RELATED

Brain chemistry imbalance revealed in violent offenders with antisocial personality disorder
LSD

Flipping two atoms in LSD turned it into a powerful treatment for damaged brain circuits

June 13, 2025

A new study introduces JRT, a modified version of LSD that promotes brain cell growth without triggering hallucinations. Researchers say this non-hallucinogenic compound could offer safer treatment options for schizophrenia and related brain disorders where psychedelics are typically contraindicated.

Read moreDetails
Neuroscience discoveries: 5 new studies offer unexpected insights into the brain
Alzheimer's Disease

Common sleep aid blocks brain inflammation and tau buildup in Alzheimer’s model

June 13, 2025

Scientists have found that lemborexant not only increased restorative sleep in male mice but also reduced levels of toxic tau and brain inflammation. The findings suggest that targeting the brain’s orexin system may help slow Alzheimer’s progression.

Read moreDetails
Brain connectivity maps shed light on the synergistic effects of meditation and psilocybin
Psychedelic Drugs

Psychedelic experiences can both cause and resolve spiritual struggles, study suggests

June 12, 2025

A new study has found that people frequently described both relief from spiritual tension and the emergence of new spiritual struggles following psychedelic use.

Read moreDetails
Meta-analysis highlights potential of psilocybin therapy for treatment-resistant depression
Depression

Psilocybin therapy shows similar benefits for patients with and without recent antidepressant use

June 11, 2025

A new study finds that individuals with treatment-resistant depression experienced similar improvements from psilocybin-assisted psychotherapy whether or not they had recently discontinued antidepressant medications.

Read moreDetails
Ayahuasca entity encounters linked to lasting religious belief changes, especially in men
Ayahuasca

Ayahuasca entity encounters linked to lasting religious belief changes, especially in men

June 8, 2025

A new study suggests that vivid encounters with perceived entities during ayahuasca experiences are associated with reduced atheism and increased spirituality, particularly among men. Before the experience, men were less religious—but gender differences disappeared afterward.

Read moreDetails
Ayahuasca retreat participants report greater gratitude and nature appreciation after the experience, study finds
Psychedelic Drugs

Psychedelics may buffer against PTSD, finds new study of survivors of Nova music festival massacre

June 7, 2025

A new study of Nova festival massacre survivors suggests that taking classic psychedelics before the attack was linked to lower anxiety and trauma symptoms weeks later, offering rare insights into how psychedelics may influence trauma memory formation in real-world settings.

Read moreDetails
Single-dose psilocybin therapy shows promise for veterans with treatment-resistant depression
Psilocybin

21-year-old man dies after jabbing pencil into his brain during psilocybin trip

June 5, 2025

A detailed case report describes how a 21-year-old man died from self-inflicted ocular trauma during a bad psilocybin trip. The tragic event illustrates how rare but extreme reactions to psychedelics can lead to fatal outcomes.

Read moreDetails
Antidepressant use in pregnancy not linked to child mental health problems after accounting for maternal depression
Depression

Antidepressant use in pregnancy not linked to child mental health problems after accounting for maternal depression

June 4, 2025

A study using U.S. medical records finds that antidepressant use during pregnancy does not increase the risk of psychiatric disorders in children when maternal mental health is accounted for, echoing results from a major Danish study.

Read moreDetails

SUBSCRIBE

Go Ad-Free! Click here to subscribe to PsyPost and support independent science journalism!

STAY CONNECTED

LATEST

Fears about AI push workers to embrace creativity over coding, new research suggests

Flipping two atoms in LSD turned it into a powerful treatment for damaged brain circuits

Seeing struggle as growth linked to higher self-esteem and life satisfaction

New research links certain types of narcissism to anti-immigrant attitudes

Common sleep aid blocks brain inflammation and tau buildup in Alzheimer’s model

The dark psychology of how people get drawn into cults

A neuroscientist explains why it’s impossible for AI to “understand” language

Parental conflict may shape how mothers discipline their children

         
       
  • Contact us
  • Privacy policy
  • Terms and Conditions
[Do not sell my information]

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Add New Playlist

Subscribe
  • My Account
  • Cognitive Science Research
  • Mental Health Research
  • Social Psychology Research
  • Drug Research
  • Relationship Research
  • About PsyPost
  • Contact
  • Privacy Policy